ImmunoPrecise Antibodies Ltd. services
Developability Profiling
In Vitro Analysis
In vitro analytical tools allow for the study of various critical quality attributes like production yield, target- and/or poly-reactivity, colloidal stability, melting temperature, self- and/or cross-interaction, solubility, and fragmentation. IPA is equipped with a state-of-the-art bio-inert HPLC enabling analytical determination of mAb biochemical and biophysical properties such as aggregation levels (SEC-HPLC), colloidal stability (SMAC-HPLC), cross interaction (CIC-HPLC), Asn deamidation and isomerization (CIEX-HPLC), and Met/Trp oxidation (HIC-HPLC).
Preclinical Services
Preclinical Services with Eurofins
Our notable partnership with industry leading?Eurofins Discovery means access to an expanded network of experts on a global scale. It enhances our capacity for single-source efficiencies and as an “end-to-end” service provider— from target evaluation through preclinical development.
Hybrid Service Model
Our hybrid of intelligence and technology platforms provide a distinctive end-to-end service model, designed to reduce time and risk with custom applications. We support our business partners in the quest to discover and develop novel antibodies against a broad range of classes of disease targets in “one-stop”, with:? An unrivaled suite of services. Target design and antigen modeling. A broad range of immunization technologies in a multitude of species and strains. Best-in-class hybridoma, B-cell, and phage display antibody discovery platforms. Antibody characterization, engineering, and manufacturing services?.